KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Opko Health (OPK) Enterprise Value (2016 - 2025)

Opko Health's Enterprise Value history spans 16 years, with the latest figure at -$369.1 million for Q4 2025.

  • For Q4 2025, Enterprise Value rose 14.55% year-over-year to -$369.1 million; the TTM value through Dec 2025 reached -$369.1 million, up 14.55%, while the annual FY2025 figure was -$369.1 million, 14.55% up from the prior year.
  • Enterprise Value reached -$369.1 million in Q4 2025 per OPK's latest filing, up from -$415.2 million in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$40.6 million in Q2 2024 to a low of -$436.0 million in Q1 2025.
  • Average Enterprise Value over 5 years is -$199.3 million, with a median of -$143.6 million recorded in 2021.
  • Peak YoY movement for Enterprise Value: skyrocketed 62.47% in 2024, then tumbled 569.65% in 2025.
  • A 5-year view of Enterprise Value shows it stood at -$134.7 million in 2021, then fell by 13.72% to -$153.2 million in 2022, then soared by 37.41% to -$95.9 million in 2023, then plummeted by 350.49% to -$431.9 million in 2024, then increased by 14.55% to -$369.1 million in 2025.
  • Per Business Quant, the three most recent readings for OPK's Enterprise Value are -$369.1 million (Q4 2025), -$415.2 million (Q3 2025), and -$271.7 million (Q2 2025).